A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an updated version developed by researchers at the University of Pittsburgh that quantifies a drug’s risk and benefits showed that the latter was more informative and helped patients feel better equipped to make decisions.
This article was originally published on MedicalXpress.com